ALNY vs BRK.B · P/E 76, rev $1.29B vs rev $371.44B
Alnylam Pharmaceuticals Inc (ALNY) versus BRK.B (BRK.B) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
BRK.B (BRK.B) common stock. It is led by Warren Buffett.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported BRK.B revenue for 2025-12-31 was $371.44B. Net income was $66.97B. Revenue was up 616.8% from 2015-12-31 to 2025-12-31. BRK.B currently screens at market cap $0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. BRK.B currently screens at market cap $0.
Not investment advice. Open the ALNY and BRK.B stock pages for the full models.
Not investment advice.